Government Intervention Measures Effectively Control COVID-19 Epidemic in Wuhan, China

Abstract

The Coronavirus disease 2019 (COVID-19) outbreak has been brought under control through a nationwide effort, and now it has become a global pandemic and the situation seems grim. We summarized the measures taken in Wuhan and analyzed the effects to comprehensively describe the factors involved in controlling the COVID-19 in China. In China, several measures such as the lockdown of Wuhan, restriction of traffic and communities, increasing hospital beds, nationwide support from medical staff, epidemic prevention equipment and supplies, and establishment of makeshift shelter hospitals have been taken. The lockdown of Wuhan reduced the propagation of cases to other cities in Hubei province and throughout China, traffic and community restrictions reduced the flow of population and the spread of disease, increasing wards and beds and medical personnel reduced the incidence of severe cases and mortality, the establishment of the Fangcang shelter hospitals provided a good isolation and monitoring environment, and further reduced the spread and fatality of the disease. The fact that China was able to control the spread of COVID-19 within three months without a specific drug or vaccine suggests that these measures are more adequate and effective.

Keywords

COVID-19 / mainland China / government intervention measures / healthcare

References

[1] HuiDS, AzharEI, MadaniTA, et al.. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis, 2020, 91: 264-266

[2] WangD, HuB, HuC, et al.. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 2020, 323(11): 1061-1069

[3] ShiH, HanX, JiangN, et al.. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis, 2020, 20(4): 425-434

[4] RockxB, KuikenT, HerfstS, et al.. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science, 2020, 368(6494): 1012-1015

[5] ChanJF, YuanS, KokKH, et al.. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020, 395(10223): 514-523

[6] XiaoF, TangM, ZhengX, et al.. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology, 2020, 158(6): 1831-1833.e3

[7] ZhaoS, LinQ, RanJ, et al.. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis, 2020, 92: 214-217

[8] ZhuN, ZhangD, WangW, et al.. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med, 2020, 382(8): 727-733

[9] ChenS, ZhangZ, YangJ, et al.. Fangcang shelter hospitals: a novel concept for responding to public health emergencies. Lancet, 2020, 395(10232): 1305-1314

[10] KraemerMUG, YangCH, GutierrezB, et al.. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science, 2020, 368(6490): 493-497

[11] PanA, LiuL, WangC, et al.. Association of Public Health Interventions with the Epidemiology of the COVID-19 Outbreak in Wuhan, China. JAMA, 2020, 323(19): 1915-1923

[12] LiuM, NingJ, DuYR, et al.. Modeling the Evolution Trajectory of COVID-19 in Wuhan, China: Experience and Suggestions. Public Health, 2020, 183: 76-80

[13] Baidu migration index. http://qianxi.baidu.com/, Accessed on March 11, 2020.

[14] New coronavirus pneumonia prevention and control program (5th ed.) (Chinese). 2020. Available at: http://www.gov.cn/zhengce/zhengceku/2020-02/05/5474791/files/de44557832ad4be1929091dcbcfca891.pdf.

[15] Wang CL, Liu L, Hao XJ, et al. Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China. Available at: https://www.medrxiv.org/content/10.1101/2020.03.03.20030593v1.

[16] YangZ, ZengZ, WangK, et al.. Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions. J Thorac Dis, 2020, 12(3): 165-174

[17] AdamsJG, WallsRM. Supporting the Health Care Workforce During the COVID-19 Global Epidemic. JAMA, 2020, 323(15): 1439-1440

[18] TongZD, TangA, LiKF, et al.. Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerg Infect Dis, 2020, 26(5): 1052-1054

[19] LiP, FuJB, LiKF, et al.. Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster. Int J Infect Dis, 2020, 96: 452-453

[20] LiC, JiF, WangL, et al.. Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China. Emerg Infect Dis, 2020, 26(7): 1626-1628